Breast cancer trends of black women compared with white women

Citation
Kc. Chu et al., Breast cancer trends of black women compared with white women, ARCH FAM M, 8(6), 1999, pp. 521-528
Citations number
53
Categorie Soggetti
General & Internal Medicine
Journal title
ARCHIVES OF FAMILY MEDICINE
ISSN journal
10633987 → ACNP
Volume
8
Issue
6
Year of publication
1999
Pages
521 - 528
Database
ISI
SICI code
1063-3987(199911/12)8:6<521:BCTOBW>2.0.ZU;2-J
Abstract
Objective: To investigate why breast cancer mortality rates have decreased in the 1990s for white women but not for black women. Design: Racial differences in breast cancer incidence, survival, and mortal ity rates were examined using regression methods and age-period-cohort mode ls. Setting: United States breast cancer mortality rates from 1970 through 1995 , breast cancer incidence rates from 1980 through 1995, and 3-year survival rates from 1980 through 1993. The incidence and survival data are from the Surveillance, Epidemiology, and End Results Program, representing 11% of t he US population, of the National Cancer Institute, Bethesda, Md. Results: For both white and black women aged 30 to 39 years, breast cancer mortality rates began decreasing in 1987. For white women aged 40 to 79 yea rs, breast cancer mortality rates declined after 1989, and for black women aged 40 to 69 years, mortality rates ceased increasing in the middle to lat e 1980s. Birth cohort trends were similar by race, but calendar period tren ds and survival rates differed. Conclusions: Declines in mortality rates in women younger than 40 years ref lect a favorable birth cohort trend for women born after 1948 and likely re flect changes in risk factors. The increased early detection of breast canc er by mammography and improvements in breast cancer treatment appear to be contributing to the improving mortality trends in older women, although bla ck women appear to have benefited less than white women from early detectio n and treatment advances. In addition, substantial increases in survival ra tes for white women with regional disease have contributed to their declini ng mortality rates and likely reflect an increasing use of beneficial adjuv ant therapy.